Keel Point Advisors’s Novo Nordisk NVO Stock Holding History

Keel Point Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$215K	Buy	+10,140	New	+$226K	0.17%	62

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Keel Point Advisors's NVO Position: Q4 2014 in Review

Keel Point Advisors opened a new position in Novo Nordisk (NVO) in Q4 2014: 10,140 shares worth $215K. The stake represents 0.17% of the portfolio and ranks #62 among its holdings.

500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

Keel Point Advisors held 10,140 shares of Novo Nordisk worth $215K as of Q4 2014.
Novo Nordisk was a new Keel Point Advisors position in Q4 2014.
Novo Nordisk made up 0.17% of Keel Point Advisors's portfolio in Q4 2014, its #62 holding.
500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Keel Point Advisors's 13F filing for Q4 2014, filed 6 Feb 2015.